Filing Details
- Accession Number:
- 0001179110-20-008422
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-23 16:07:48
- Reporting Period:
- 2020-07-21
- Accepted Time:
- 2020-07-23 16:07:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1706857 | Santiago Arroyo | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-21 | 10,156 | $12.76 | 38,935 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-07-21 | 22,500 | $17.20 | 61,435 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2020-07-21 | 49,967 | $34.62 | 11,468 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-22 | 1,939 | $32.32 | 9,529 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-21 | 10,156 | $0.00 | 10,156 | $12.76 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-21 | 22,500 | $0.00 | 22,500 | $17.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 94,014 | 2020-02-11 | 2029-02-11 | No | 4 | M | Direct |
| 81,748 | 2018-12-20 | 2027-06-20 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $34.23 to $35.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- This transaction was executed in multiple trades at prices ranging from $31.33 to $34.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
